LINC02934: A Non-Coding RNA Molecule with Potential as a Drug Target or Biomarker

Target Name: LINC02934

NCBI ID: G105369168

LINC02934

Other Name(s): LOC105369168 variant X2 | long intergenic non-protein coding RNA 2934 | Uncharacterized LOC105369168, transcript variant X2

LINC02934: A Non-Coding RNA Molecule with Potential as a Drug Target or Biomarker

LINC02934 (LOC105369168) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. The molecule is derived from the genomic region encoding the protein ZNF2, which is a transcription factor that plays a crucial role in the development and maintenance of neural stem cells.

ZNF2 is a protein that is expressed in a wide range of tissues and cells, including brain, spinal cord, and peripheral tissues. It is known to play a role in the regulation of neuronal stem cell proliferation and differentiation, as well as in the development and maintenance of neural circuits.

LINC02934 is a non-coding RNA molecule that is derived from the genomic region encoding ZNF2. It is characterized by the presence of a unique stem-loop structure, which is a common feature of RNA molecules that play a role in the regulation of gene expression . The stem-loop region of LINC02934 is composed of a series of alternating double-stranded RNA secondary structures, which give the molecule its unique 3D structure.

The role of LINC02934 in the regulation of ZNF2 expression and function is not yet fully understood. However, studies have shown that LINC02934 can interact with ZNF2 and that it is expressed in a similar pattern to ZNF2 in various tissues and cells.

One of the most promising aspects of LINC02934 is its potential as a drug target. The molecule has been shown to be highly sensitive to small molecules, such as inhibitors, which suggests that it may be an attractive target for the development of new therapies for a variety of neurological and psychiatric disorders.

In addition to its potential as a drug target, LINC02934 also has the potential as a biomarker. The molecule is expressed in a wide range of tissues and cells, including brain, spinal cord, and peripheral tissues, which makes it a potential candidate for use as a diagnostic or predictive marker for a variety of neurological and psychiatric disorders.

Overall, LINC02934 is a promising molecule for the development of new therapies and biomarkers for a variety of neurological and psychiatric disorders. Further research is needed to fully understand its role in the regulation of ZNF2 expression and function, as well as its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2934

The "LINC02934 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02934 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets